Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

MULTIPLE INHIBITORY EFFECTS OF α-METHYLAMIND ACIDS ON THE METABOLISM OF C14-LABELED TYROSENE, DOPA AND α-METHYLDOPA

J. F. Moran and T. L. Sourkes
Journal of Pharmacology and Experimental Therapeutics May 1965, 148 (2) 252-261;
J. F. Moran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. L. Sourkes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

This article has a correction. Please see:

  • MULTIPLE INHIBITORY EFFECTS OF α-METHYLAMIND ACIDS ON THE METABOLISM OF C14-LABELED TYROSENE, DOPA AND α-METHYLDOPA - August 01, 1965

Abstract

A series of "decarboxylase inhibitors" including α-methyldopa, α-methyl- m-tyrosine and α-hydrazino-α-methyl-3, 4-dihydroxyphenylpropionic acid have been examined for their effects on formation of respiratory C14 O2 from intraperitoneally administered C14-labeled d- and l-tyrosine, d -and dl-dopa, and l-α-methyldopa. Substantial inhibition of C14 O2 expiration after injection of both carboxyl-and β labeled tyrosine has been observed in animals receiving α-methyldopa, α-methyl-m-tyrosine and the hydrazino analogue of a-methyldopa. The results establish the fact that the a-methylamino acids inhibit enzymes on the main pathway of degradation of tyrosine; their inhibitory action cannot be explained simply on the basis of their well-known antidecarboxylase properties. By comparing the effects of the inhibitors on carboxyl-labeled d-and 1-tyrosine it has been shown that the hydrazino analogue of α-methyl dopa inhibits l-tyrosine-α-ketoglutarate transaminase; α-methyldopa and α-methyl-m-tyrosine inhibit d-amino acid oxidase and, perhaps, also the transaminase or p-hydroxyphenylpyruvate oxidase (or both).

Inhibition of d-amino acid oxidase by α-methyldopa, α-methyl-m-tyrosine and α-meth-ylmethionine was also observed in experiments with d-and dl-dopa labeled in the carboxyl group. However, the hydrazino compound inhibited the two forms of dopa to the same extent; this result has been discussed in relation to the metabolic fate of 3, 4-dihydroxyphenylpyruvic acid, the presumed first intermediate in the catabolism of d-dopa.

α-Methyldopa, α-methyl-m-tyrosine, α-hydrazino-α-methyl-3, 4-dihydroxyphenyipropionic acid, α-methyl-5-hydroxytryptophan, and 5-(3-hydroxycinnamoyl) salicylic acid are effective in inhibiting C14 O2 formation from carboxyllabeled dl-dopa and lα-methyldopa, thus confirming their "antidecarboxylase" action. However, in experiments utilizing carboxyl-labeled l-tyrosine, α-methyl-5-hydroxytryptophan and the salicylic acid derivative did not inhibit the formation of respiratory C14O2. It has thus been shown that by the judicious choice of substrate and its labeling in this type of experiment, the specificity of action of the "antidecarboxylases" can be determined in vivo and their other sites of action elucidated.

Footnotes

    • Accepted January 12, 1965.
  • The Williams & Wilkins Comapny

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 148, Issue 2
1 May 1965
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
MULTIPLE INHIBITORY EFFECTS OF α-METHYLAMIND ACIDS ON THE METABOLISM OF C14-LABELED TYROSENE, DOPA AND α-METHYLDOPA
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

MULTIPLE INHIBITORY EFFECTS OF α-METHYLAMIND ACIDS ON THE METABOLISM OF C14-LABELED TYROSENE, DOPA AND α-METHYLDOPA

J. F. Moran and T. L. Sourkes
Journal of Pharmacology and Experimental Therapeutics May 1, 1965, 148 (2) 252-261;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

MULTIPLE INHIBITORY EFFECTS OF α-METHYLAMIND ACIDS ON THE METABOLISM OF C14-LABELED TYROSENE, DOPA AND α-METHYLDOPA

J. F. Moran and T. L. Sourkes
Journal of Pharmacology and Experimental Therapeutics May 1, 1965, 148 (2) 252-261;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Down-Regulation of Rat Hepatic Microsomal Cytochromes P-450 in Microvesicular Steatosis Induced by Orotic Acid
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics